2005 - BSc Basic Clinical Sciences - St George's Hospital Medical School (University of London)
2008 - MBBS Medicine - St George's Hospital Medical School (University of London)
2011 - MSc Immunology with Immunogenetics - University of Manchester
2014 - MRCP (London)
2018 - PhD Immunology (medicine) - University of Manchester
Analysis of advice and guidance primary care queries to rheumatology over a calendar year—a diagnostic service evaluation E O’Shaughnessy, B Mulhearn, M Bukhari Rheumatology Advances in Practice, rkag054 , 2026 2026
P047 Analysis of advice and guidance primary care queries to rheumatology over a calendar year-a mixed methods approach EA O’Shaughnessy, M Bukhari, B Mulhearn Rheumatology 65 (Supplement_2), keag121. 083 , 2026 2026
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation V Quick, S Sah, S Dubey, L Mercer, JR Nair, FL Coath, M Kurshid, ... Rheumatology 65 (1), keaf450 , 2026 2026 Citations: 2
Prescribing habits before and after regulation change: a British perspective B Mulhearn, M Bukhari Rheumatology 64 (5), 2341-2342 , 2025 2025
P113 Cellular profiling of synovial fluid in inflammatory arthritis highlights disease-specific cell states with biological and diagnostic relevance M Christofi, S Valma, L Marshall, B Mulhearn, T Hussell, A Barton, ... Rheumatology 64 (Supplement_3), keaf142. 153 , 2025 2025
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England V Quick, M Abusalameh, S Ahmed, H Alkoky, M Bukhari, S Carter, ... Rheumatology 63 (12), 3407-3414 , 2024 2024 Citations: 21
The development and validation of a novel training infographic for the physician global visual analog scale in psoriatic arthritis S Gunawardana, PS Helliwell, MR Kok, M Vis, A Allard, A Akpabio, ... The Journal of rheumatology 51 (11), 1084-1091 , 2024 2024 Citations: 4
OP0111 QUIESCENT HUMAN BLOOD MONOCYTE STATES ARE PRE-COMMITTED TO AN INFLAMMATORY SYNOVIAL TRANSCRIPTIONAL PROGRAM E Amies, M Christofi, B Mulhearn, L Marshall, M Sutcliffe, K Hyrich, ... Annals of the Rheumatic Diseases 83, 198-199 , 2024 2024
POS0248 THE EVALUATION OF A NOVEL TRAINING INFOGRAPHIC FOR THE PHYSICIAN VISUAL ANALOGUE SCALE (VAS) IN PSORIATIC ARTHRITIS S Gunawardana, PS Helliwell, MR Kok, M Vis, A Allard, A Akpabio, ... Annals of the Rheumatic Diseases 83, 371-372 , 2024 2024
OP0307 CELLULAR PROFILING OF SYNOVIAL FLUID IN INFLAMMATORY ARTHRITIS HIGHLIGHTS SHARED AND DISEASE-SPECIFIC CELL STATES WITH BIOLOGICAL AND DIAGNOSTIC RELEVANCE M Christofi, S Valma, L Marshall, B Mulhearn, T Hussell, A Barton, D Rao, ... Annals of the Rheumatic Diseases 83, 17 , 2024 2024
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England H Alkoky, M Bukhari, S Carter, FL Coath, B Davidson, P Doddamani, ... OUP , 2023 2023
Extent of Recording of 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a UK Healthcare Database J Ellis, A McGrogan, N McHugh, B Mulhearn, E Korendowych, J Pauling, ... ARTHRITIS & RHEUMATOLOGY 75, 258-259 , 2023 2023
Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley Heliyon 9 (7) , 2023 2023 Citations: 11
POS0726 Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis: A Cost Analysis E Amor, B Mulhearn, W Tillett, C Cavill, S Tansley Annals of the Rheumatic Diseases 82 (Suppl 1), 651-651 , 2023 2023 Citations: 1
Automated clustering reveals CD4 + T cell subset imbalances in rheumatoid arthritis B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ... Frontiers in Immunology 14, 1094872 , 2023 2023 Citations: 14
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported … B Mulhearn Annals of the rheumatic diseases 82 (5), e115 , 2023 2023
Monocular Vision Loss in a Patient With Earache and Night Sweats S Schimansky, G Cross, B Mulhearn JAMA ophthalmology 141 (4), 396-397 , 2023 2023
P208 PET-CT scanning of GCA patients: the additive role of opportunistic screening for cardiovascular disease in a high-risk population B Mulhearn, J Ellis, R Foley, S Gunawardana, R Wickramarachchi, ... Rheumatology 62 (Supplement_2), kead104. 249 , 2023 2023
P110 Challenges of meeting NICE guidance for rheumatoid arthritis in the modern era: a service audit H Cooney, J Ellis, B Mulhearn, A Allard Rheumatology 62 (Supplement_2), kead104. 151 , 2023 2023
E070 How well is the mental health of rheumatoid arthritis patients assessed in the routine rheumatology clinic? H Cooney, J Ellis, B Mulhearn, A Allard Rheumatology 62 (Supplement_2), kead104. 319 , 2023 2023 Citations: 1
MOST CITED SCHOLAR PUBLICATIONS
Indications for IVIG in rheumatic diseases B Mulhearn, IN Bruce Rheumatology 54 (3), 383-391 , 2015 2015 Citations: 119
Autoantibodies in connective tissue disease B Mulhearn, SL Tansley, NJ McHugh Best Practice & Research Clinical Rheumatology 34 (1), 101462 , 2020 2020 Citations: 37
Using the immunophenotype to predict response to biologic drugs in rheumatoid arthritis B Mulhearn, A Barton, S Viatte Journal of Personalized Medicine 9 (4), 46 , 2019 2019 Citations: 35
A commercial anti-TIF1γ ELISA is superior to line and dot blot and should be considered as part of routine myositis-specific antibody testing B Mulhearn, D Li, F McMorrow, H Lu, NJ McHugh, SL Tansley Frontiers in Immunology 13, 804037 , 2022 2022 Citations: 22
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England V Quick, M Abusalameh, S Ahmed, H Alkoky, M Bukhari, S Carter, ... Rheumatology 63 (12), 3407-3414 , 2024 2024 Citations: 21
The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population A Loganathan, F McMorrow, H Lu, D Li, B Mulhearn, NJ McHugh, ... Frontiers in immunology 13, 975939 , 2022 2022 Citations: 15
Automated clustering reveals CD4 + T cell subset imbalances in rheumatoid arthritis B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ... Frontiers in Immunology 14, 1094872 , 2023 2023 Citations: 14
What rheumatologists need to know about innate lymphocytes MA Exley, GC Tsokos, KHG Mills, D Elewaut, B Mulhearn Nature Reviews Rheumatology 12 (11), 658-668 , 2016 2016 Citations: 12
Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley Heliyon 9 (7) , 2023 2023 Citations: 11
Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary … SL Barratt, HH Adamali, C Cotton, B Mulhearn, H Iftikhar, JD Pauling, ... BMJ Open Respiratory Research 8 (1) , 2021 2021 Citations: 11
The development and validation of a novel training infographic for the physician global visual analog scale in psoriatic arthritis S Gunawardana, PS Helliwell, MR Kok, M Vis, A Allard, A Akpabio, ... The Journal of rheumatology 51 (11), 1084-1091 , 2024 2024 Citations: 4
P290 Baseline monocyte count may help make a diagnosis of giant cell arteritis: results of routinely collected audit data from two centres B Mulhearn, J Ellis, T Somoskeoy, A Bourn, S Knights, S Skeoch, ... Rheumatology 61 (Supplement_1), keac133. 289 , 2022 2022 Citations: 3
Rituximab fails to treat giant cell arteritis in a patient with ACPA-positive rheumatoid arthritis B Mulhearn, E Cooper, S Knights Rheumatology Advances in Practice 5 (1), rkab020 , 2021 2021 Citations: 3
Coming to a hard stop? Effect of tapered tocilizumab after weekly tocilizumab cessation for GCA: a multicentre evaluation V Quick, S Sah, S Dubey, L Mercer, JR Nair, FL Coath, M Kurshid, ... Rheumatology 65 (1), keaf450 , 2026 2026 Citations: 2
POS0726 Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis: A Cost Analysis E Amor, B Mulhearn, W Tillett, C Cavill, S Tansley Annals of the Rheumatic Diseases 82 (Suppl 1), 651-651 , 2023 2023 Citations: 1
E070 How well is the mental health of rheumatoid arthritis patients assessed in the routine rheumatology clinic? H Cooney, J Ellis, B Mulhearn, A Allard Rheumatology 62 (Supplement_2), kead104. 319 , 2023 2023 Citations: 1
OP0281 EXCESS GIANT CELL ARTERITIS CASES ARE ASSOCIATED WITH PEAKS IN COVID-19 PREVALENCE B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley Annals of the Rheumatic Diseases 80, 170 , 2021 2021 Citations: 1
145 The British Society for Rheumatology’s Choosing Wisely UK recommendations CA Sharp, IN Bruce, BM Ellis, S Elkhalifa, J Galloway, B Mulhearn, J Firth, ... Rheumatology 58 (Supplement_3), kez108. 053 , 2019 2019 Citations: 1
Identifying immune biomarkers to predict treatment response to biologic drugs in rheumatoid arthritis B Mulhearn PQDT-UK & Ireland , 2018 2018 Citations: 1
Analysis of advice and guidance primary care queries to rheumatology over a calendar year—a diagnostic service evaluation E O’Shaughnessy, B Mulhearn, M Bukhari Rheumatology Advances in Practice, rkag054 , 2026 2026
